Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
84
pubmed:dateCreated
2008-8-18
pubmed:abstractText
Herein is described a mesenteric diffuse large B cell lymphoma (DLBCL) case with a bulky mass which had achieved a complete remission by the combination therapy of a surgical resection and the CHOP chemotherapy with rituximab. A 78 year old man was referred to the Rakuwakai-Otowa Hospital due to a left lower abdominal tumor. Abdominal CT and MRI showed a bowel-like mass in the left lower abdominal cavity. Abdominal US revealed lymph node swellings at the paraaortic region. By the gastro-duodenoscopy, DLBCL of non-Hodgkin's lymphoma was proven at the 2nd portion of the duodenum. On laparotomy, a mass of 8x8cm in size was found at the mesenterium of the ileum, which directly invaded the ileum and the sigmoid mesocolon. A partial resection of the ileum and the sigmoid colon was performed. After the operation, it was determined to be Stage IV DLBCL and the chemotherapy based on the R-CHOP regimen was performed. The regimen was repeated to the 6th course. During the chemotherapy, he was confirmed to have achieved a complete remission. The present case is a rare case in which a Stage IV mesenteric DLBCL with extensive bulky masses had a favorable prognosis. Stage IV mesenteric DLBCLs with extensive bulky masses are thought to be the indication for the combination therapy of surgical resection and multiagent chemotherapy with rituximab.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0172-6390
pubmed:author
pubmed:issnType
Print
pubmed:volume
55
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
891-4
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:18705290-Aged, pubmed-meshheading:18705290-Antibodies, Monoclonal, pubmed-meshheading:18705290-Antibodies, Monoclonal, Murine-Derived, pubmed-meshheading:18705290-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:18705290-Chemotherapy, Adjuvant, pubmed-meshheading:18705290-Colon, Sigmoid, pubmed-meshheading:18705290-Combined Modality Therapy, pubmed-meshheading:18705290-Cyclophosphamide, pubmed-meshheading:18705290-Doxorubicin, pubmed-meshheading:18705290-Humans, pubmed-meshheading:18705290-Ileum, pubmed-meshheading:18705290-Lymph Nodes, pubmed-meshheading:18705290-Lymphoma, Large B-Cell, Diffuse, pubmed-meshheading:18705290-Magnetic Resonance Imaging, pubmed-meshheading:18705290-Male, pubmed-meshheading:18705290-Mesentery, pubmed-meshheading:18705290-Neoplasm Invasiveness, pubmed-meshheading:18705290-Neoplasm Staging, pubmed-meshheading:18705290-Peritoneal Neoplasms, pubmed-meshheading:18705290-Prednisolone, pubmed-meshheading:18705290-Tomography, X-Ray Computed, pubmed-meshheading:18705290-Vincristine
pubmed:articleTitle
Surgical resection combined with CHOP chemotherapy plus rituximab for a patient with advanced mesenteric diffuse large B cell lymphoma.
pubmed:affiliation
Department of Surgery, Rakuwakai-Otowa Hospital, Yamashina-ku, Kyoto 607-8062, Japan. rakuwadr011@rakuwadr.com
pubmed:publicationType
Journal Article, Case Reports